Inspiratory Muscle Training in Patients With COVID-19

Covid19 Clinical Trial

Official title: Efects of Inspiratory Muscle Training in Patients With COVID-19 After Acute Phase. Prospective Study

Status Terminated

Clinical Trial Summary

COVID 19 has become a pandemic and has led to high demand on healthcare systems. It can cause a severe acute respiratory syndrome (SARS CoV-2) which leads to a long hospital stay, developing important functional damage and making hospital discharge difficult. Elderly, obese and people with chronic diseases are more susceptible to contracting the disease, this profile of patients already has a predisposition for respiratory muscle weakness and in this context, after clinical stability, it is still necessary in a hospital environment to approach respiratory and motor physiotherapy. to optimize the recovery of these patients. Objective: Improved breathing, functionality, exercise capacity and muscle strength in non-critical patients. Method: Prospective randomized clinical study where one group received motor and respiratory physiotherapy and the other group performed the same therapy associated with inspiratory muscle training. Results: The findings will be compared before and after the approach and will be presented in graphs and tables. Statistical tests will be used considering a significance level of 5%.

Clinical Trial Description

Prospective clinical study in patients with COVID-19 admitted to a non-critical unit of a tertiary hospital. They were randomized into a group that received motor and respiratory exercises and another group that received the same exercises associated with respiratory muscle training. ;

Related Conditions & MeSH terms

• Covid19
• Respiration Disorders
• Respiratory Disease
• Respiratory Tract Diseases

• NCT number: NCT04603963
• Study type: Interventional
• Source: Hospital Israelita Albert Einstein
• Status: Terminated
• Phase: N/A
• Start date: June 1, 2020
• Completion date: October 23, 2020